PRODUCTS
SERVICES
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
2.02
1 yrs 8 m
1%
1,704.87 Crs
1% on or before 30D, Nil after 30D
Large Growth
7.47
SIP 100 & Lumpsum 100
NA
Nikhil Mathur
Investors understand that their principal will be at very high risk